Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Immuneering Corporation (IMRX) had Free Cash Flow per Share of $-1.03 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-56.02M |
|
-- |
|
-- |
|
$59.38M |
|
$-59.38M |
|
$3.35M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-59.38M |
|
$-58.83M |
|
44.01M |
|
44.01M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$176.25M |
|
$0.94M |
|
$55.74M |
|
$231.99M |
|
$10.07M |
|
-- |
|
$3.43M |
|
$13.50M |
|
$218.48M |
|
$211.47M |
|
$218.48M |
|
64.65M |
|
| Cash Flow Statement Financials | |
$-45.34M |
|
$-88.74M |
|
$226.58M |
|
$36.14M |
|
$128.65M |
|
$92.50M |
|
$6.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.64% |
|
-26.49% |
|
-24.15% |
|
-25.64% |
|
$3.38 |
|
|
Free Cash Flow per Share |
$-1.03 |
$-1.03 |
|